Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Humanized mouse models provide a more accurate representation of the human immune microenvironment. This manuscript describes the process in which these models are created through a renal graft of human thymus, injection of human CD34+ cells, and the targeted delivery of human cytokine transgenes to promote CD34+ cell proliferation and differentiation.

Abstract

Animal models provide a vital translation between in vitro and in vivo biomedical research. Humanized mouse models provide a bridge in the representation of human systems, thereby allowing for a more accurate study of pathogenesis, biomarkers, and many other scientific queries. In this method described, immune-deficient NOD-scid IL2Rγnull (NSG) mice are implanted with autologous thymus, injected with liver-derived CD34+ cells followed by a series of injected cytokine deliveries. In contrast to other models of a similar nature, the model described here promotes an improved reconstitution of immune cells by delivering cytokines and growth factors via transgenes encoded in AAV8 or pMV101 DNA-based vectors. Moreover, it offers long-term stability with reconstituted mice having an average lifespan of 30 weeks after CD34+ injections. Through this model, we hope to provide a stable and impactful method of studying immunotherapy and human disease in a murine model, thus demonstrating the need for predictive preclinical models.

Introduction

While animal models have created a deeper understanding of cellular and molecular systems, the challenge remains in elucidating the intricacies of species-specific systems, such as immunity, physiology, and other areas of pathology. Non-human primates (NHP), such as chimpanzees, have historically been used to compensate for the wanting gaps in model research; however, the NHP model can be quite costly and inaccessible, particularly as their use has been banned in Europe1.

Following a successful grafting procedure, the murine system replicates the human immune system, as demonstrated through the repopulation of the ly....

Protocol

All protocols involving the use of animals are closely monitored by the Wistar Institute's Institutional Animal Care and User Committee (IACUC). The laboratory adheres to the guidelines set by this committee and the attending veterinarian to ensure the health, safety, and wellbeing of the animals involved. Prior to following this protocol, veterinarian and IACUC approval are required, and individuals may have variations in the specific surgical techniques and animal handling compared to the protocol per the advice of.......

Representative Results

Following successful surgery and appropriate postoperative injections, CD34+ differentiation can be confirmed via flow cytometry. Approximately 8 weeks after surgery, mice are bled in preparation for FACS, recurring every 2 weeks until a specific threshold of human immune cells is met as is described previously10. Briefly, 100 mL of blood was collected in blood collection tubes coated with lithium and heparin. After the lysis of red blood cells using ACK lysis buffer, the cells were was.......

Discussion

This manuscript has herein described generating humanized mice via human fetal thymus grafted under the renal capsule and subsequent CD34+ injection to recreate a human immune system.

While the protocol functions to create the best model possible, certain steps are essential to viability. For example, during the CD34+ isolation, it is essential that one looking through the microscope can identify CD34+ cells. Though it may seem redundant, automatic counting mac.......

Acknowledgements

Thanks to Wistar Flow-Cytometry, Molecular Screening, Vector Core, and Animal Facility for their support. This work was made possible with support from the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation.

....

Materials

NameCompanyCatalog NumberComments
ACK lysis bufferLife Technologies Corporation
BD MicrocontainerBDblood collection tubes
BusulfanSigmaB2635-25gIrradiating drug; light sensitive
CD34 MicrobeadsMiltenyi Biotec130-046-702antibody beads kit; stored at 4 °C
CKITAldevroncustomcytokine; stored at -20 °C
Collagenase/DispaseRoche Diagnostics11097113001Stored at 4 °C
FcR Blocking reagentMiltenyi Biotec130-046-702antibody beads kit; stored at 4 °C
Fetal tissue (liver and thymus)Advanced Bioscience ResourcesDelivered same day or overnight
FicollGE Healthcare17-1440-03Stored at room temperature
FLT3Aldevron125964cytokine; stored at -20 °C
ForcepsVariousVarious
Hamilton syringe needleVariousVarious22 G; 3 point; 2" length
HemostatsVariousVarious
MS columnsMiltenyi Biotec130-042-201magnetic separator
PBSGibco14190-136Stored at room temperature
PrimocinInvivogenamt-pm1antibiotic; stored at 4 °C
RPMICorning10-040-CMStored at 4 °C
SCFAldevron125962cytokine; stored at -20 °C
Surgical scissorsVariousVarious
THPOAldevron125963cytokine; stored at -20 °C
Tissue treated petri dishCorning430167
VetBond glue3M1469SBglue
Visorb sutureStoelting Co5046absorbable suture, size 4, 19 mm cutting

References

  1. Fujiwara, S. Humanized mice: A brief overview on their diverse applications in biomedical research. Journal of Cellular Physiology. 233 (4), 2889-2901 (2017).
  2. Singh, K. S., et al. IspH inhibito....

Explore More Articles

Humanized Mouse ModelThymic Renal Capsule GraftingCD34 Cell InjectionCytokine DeliveryImmune Cell ReconstitutionNOD scid IL2R null NSG MiceAAV8PMV101ImmunotherapyHuman Disease Modeling

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved